AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin

In recurrent epithelial ovarian cancer (EOC) most patients develop platinum-resistance. On molecular level the NRF2 pathway, a cellular defense mechanism against reactive oxygen species, is induced. In this study, we investigate AKR1C1/2, target of NRF2, in a well-established EOC collective by immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Badmann, Susann, Mayr, Doris, Schmoeckel, Elisa, Hester, Anna, Buschmann, Christina, Beyer, Susanne, Kolben, Thomas, Kraus, Fabian, Chelariu-Raicu, Anca, Burges, Alexander, Mahner, Sven, Jeschke, Udo, Trillsch, Fabian, Czogalla, Bastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814148/
https://www.ncbi.nlm.nih.gov/pubmed/35115586
http://dx.doi.org/10.1038/s41598-022-05785-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814148/
https://www.ncbi.nlm.nih.gov/pubmed/35115586
http://dx.doi.org/10.1038/s41598-022-05785-9

Ejemplares similares